Moderna (MRNA) Insider Trading & Ownership $41.11 +2.86 (+7.48%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Moderna (NASDAQ:MRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$81.36 M Get MRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Moderna stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRNA Insider Buying and Selling by Quarter Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Moderna Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/7/2024James M MockCFOSell715$60.12$42,985.80 9/3/2024Shannon Thyme KlingerInsiderSell114$76.99$8,776.86 9/3/2024Stephen HogePresidentSell318$76.99$24,482.82 8/29/2024Shannon Thyme KlingerInsiderSell162$78.03$12,640.86 8/29/2024Stephen HogePresidentSell300$78.03$23,409.00 8/28/2024James M MockCFOSell1,321$79.39$104,874.19 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/12/2024Stephen HogePresidentSell254$84.10$21,361.40 7/31/2024Noubar AfeyanDirectorSell15,000$119.96$1,799,400.00 7/24/2024Noubar AfeyanDirectorSell15,000$117.80$1,767,000.00 7/17/2024Noubar AfeyanDirectorSell15,000$122.84$1,842,600.00 7/15/2024Stephen HogePresidentSell15,000$121.12$1,816,800.00 7/10/2024Noubar AfeyanDirectorSell15,000$117.08$1,756,200.00 7/8/2024James M MockCFOSell689$118.24$81,467.36 6/26/2024Noubar AfeyanDirectorSell15,000$127.22$1,908,300.00 6/17/2024Stephen HogePresidentSell15,000$138.16$2,072,400.00 6/11/2024Noubar AfeyanDirectorSell202,832$148.34$30,088,098.88 6/10/2024Shannon Thyme KlingerInsiderSell5,178$148.09$766,810.02 6/5/2024Noubar AfeyanDirectorSell15,000$151.25$2,268,750.00 5/29/2024Noubar AfeyanDirectorSell20,000$145.08$2,901,600.00 5/29/2024Stephen HogePresidentSell341$144.50$49,274.50 5/28/2024James M MockCFOSell648$162.47$105,280.56 5/28/2024Shannon Thyme KlingerInsiderSell1,296$162.47$210,561.12 5/22/2024Noubar AfeyanDirectorSell15,000$157.57$2,363,550.00 5/15/2024Noubar AfeyanDirectorSell15,000$127.32$1,909,800.00 5/10/2024Stephen HogePresidentSell255$120.96$30,844.80 5/8/2024Noubar AfeyanDirectorSell15,000$121.68$1,825,200.00 5/1/2024Noubar AfeyanDirectorSell15,000$110.92$1,663,800.00 4/24/2024Noubar AfeyanDirectorSell15,000$108.32$1,624,800.00 4/17/2024Noubar AfeyanDirectorSell15,000$103.38$1,550,700.00 4/15/2024Stephen HogePresidentSell15,000$105.02$1,575,300.00 4/10/2024Noubar AfeyanDirectorSell15,000$107.12$1,606,800.00 4/8/2024James M MockCFOSell705$101.93$71,860.65 4/3/2024Noubar AfeyanDirectorSell15,000$101.68$1,525,200.00 3/27/2024Noubar AfeyanDirectorSell15,000$109.06$1,635,900.00 3/20/2024Noubar AfeyanDirectorSell15,000$102.39$1,535,850.00 3/13/2024Noubar AfeyanDirectorSell15,000$108.54$1,628,100.00 3/8/2024Shannon Thyme KlingerInsiderSell544$99.05$53,883.20 2/29/2024James M MockCFOSell647$94.57$61,186.79 2/29/2024Shannon Thyme KlingerInsiderSell670$94.57$63,361.90 2/29/2024Stephen HogePresidentSell2,388$94.57$225,833.16 Automatic Income (from home) (Ad)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video2/1/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$99.02$1,001 - $15,0001/16/2024Stephen HogePresidentSell15,000$103.90$1,558,500.00 1/8/2024James M MockCFOSell772$109.75$84,727.00 12/27/2023Stephen HogePresidentSell45,000$100.01$4,500,450.00 12/27/2023Stephen HogePresidentSell45,000$100.01$4,500,450.00 12/8/2023Shannon Thyme KlingerInsiderSell563$79.09$44,527.67 12/6/2023Arpa GarayInsiderSell564$78.34$44,183.76 (Data available from 1/1/2013 forward) MRNA Insider Trading Activity - Frequently Asked Questions Who is on Moderna's Insider Roster? The list of insiders at Moderna includes Arpa Garay, David W Meline, James M Mock, Juan Andres, Noubar Afeyan, Shannon Thyme Klinger, Stephane Bancel, and Stephen Hoge. Learn more on insiders at MRNA. What percentage of Moderna stock is owned by insiders? 15.70% of Moderna stock is owned by insiders. Learn more on MRNA's insider holdings. Which Moderna insiders have been selling company stock? The following insiders have sold MRNA shares in the last 24 months: Arpa Garay ($44,183.76), James M Mock ($845,327.35), Juan Andres ($1,249,193.20), Noubar Afeyan ($117,803,348.88), Shannon Thyme Klinger ($1,389,442.45), Stephane Bancel ($147,125,262.65), and Stephen Hoge ($24,045,640.93). How much insider selling is happening at Moderna? Insiders have sold a total of 2,080,429 Moderna shares in the last 24 months for a total of $292,502,399.22 sold. Which members of congress are trading Moderna? Josh Gottheimer (D-NJ) has sold shares of Moderna in the last year totaling $8,000. Moderna Key ExecutivesMr. Stephane Bancel (Age 51)Chief Executive Officer Compensation: $4.55MDr. Stephen Hoge M.D. (Age 47)President Compensation: $1.92MMr. James M. Mock (Age 47)Chief Financial Officer Compensation: $1.4M4 recent tradesMs. Shannon Thyme Klinger (Age 53)Chief Legal Officer & Corporate Secretary Compensation: $1.39M4 recent tradesDr. Jerh Collins Ph.D. (Age 57)Chief Technical Operations & Quality Officer Mr. Brad Miller (Age 50)Chief Information Officer Ms. Lavina Talukdar CFASenior VP & Head of Investor RelationsColleen HusseySenior Director of Corporate CommunicationsMs. Tracey Franklin (Age 43)Chief Human Resources Officer Dr. Melanie Ivarsson M.B.A.Ph.D., Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Neurocrine Biosciences Insider Trades Bio-Techne Insider Trades Repligen Insider Trades Biogen Insider Trades CRISPR Therapeutics Insider Trades Denali Therapeutics Insider Trades Takeda Pharmaceutical Insider Trades BioNTech Insider Trades Teva Pharmaceutical Industries Insider Trades BeiGene Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:MRNA) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free mrna Stock Alerts